From: Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination
Variable | HR | 95% CI | p value |
---|---|---|---|
OS in gastric cancer patients | |||
Palliative gastrectomy (Gastrectomy vs. without gastrectomy)a | 0.772 | 0.516–1.154 | 0.207 |
Tumor size (<5, ≥5, and <10 vs. ≥10 cm) | 1.016 | 0.771–1.339 | 0.910 |
Tumor location (Upper, middle, and lower vs. total) | 1.314 | 1.070–1.614 | 0.009 |
Ascite (With vs. without) | 0.969 | 0.653–1.438 | 0.877 |
Peritoneal seeding grade (P1 and P2 vs. P3) | 1.507 | 1.178–1.928 | 0.001 |
Serum CEA Level (Normal vs. elevated) | 1.356 | 0.915–2.011 | 0.129 |
Serum CA19-9 Level (Normal vs. elevated) | 1.384 | 0.943–2.031 | 0.097 |
BMI group (<18.5 and 18.5–23 vs. >23) | 0.871 | 0.654–1.161 | 0.346 |